Switch to Quad Pill Maintained HIV Suppression (CME/CE)
HIV patients can be successfully switched from a twice-daily integrase inhibitor regimen to a once-daily, single-tablet regimen without loss of viral suppression, researchers reported here.
At 48 weeks, all 46 patients who switched from a raltegravir-based (Isentress) regimen to the four-drug, elvitegravir-cobicistat-tenofovir-emtricitabine (Stribild) pill were able to maintain undetectable viral load using the 50 copies/ml assay, said Gordon Crofoot, MD, a Houston-based HIV researcher in private practice.
Showing posts with label Suppression. Show all posts
Showing posts with label Suppression. Show all posts
Monday, August 5, 2013
Wednesday, July 31, 2013
Prezista Extends HIV Suppression in Children (CME/CE)
Prezista Extends HIV Suppression in Children (CME/CE)
Children with human immunodeficiency virus (HIV) maintain viral control for 48 weeks when treated with the protease inhibitor darunavir/ritonavir (Prezista) along with an optimized background regimen, researchers reported here.
In the Darunavir in Treatment Experienced Pediatric Population (ARIEL) study, 81% of the 21 children ages 3 to 5 years were able to achieve viral suppression to undetectable limits using the 50 copies/ml assay, an increase from the 57% viral suppression rate at 24 weeks, said Avy Violari, MD, deputy executive director of the Perinatal HIV Research Unit at Chris Hani Baragwaneth Hospital, Soweto, South Africa.
Children with human immunodeficiency virus (HIV) maintain viral control for 48 weeks when treated with the protease inhibitor darunavir/ritonavir (Prezista) along with an optimized background regimen, researchers reported here.
In the Darunavir in Treatment Experienced Pediatric Population (ARIEL) study, 81% of the 21 children ages 3 to 5 years were able to achieve viral suppression to undetectable limits using the 50 copies/ml assay, an increase from the 57% viral suppression rate at 24 weeks, said Avy Violari, MD, deputy executive director of the Perinatal HIV Research Unit at Chris Hani Baragwaneth Hospital, Soweto, South Africa.
Labels:
Children,
CMECE,
Extends,
Prezista,
Suppression
Sunday, June 30, 2013
Why So Many People Fail In Affiliate Marketing
Why So Many People Fail In Affiliate Marketing
More and More people are lured into affiliate marketing and you might be one of them. Indeed, affiliate marketing is one of the most effective means of generating a full-time income through the Internet. It’s a fair deal between the merchandiser and his affiliates as both benefit from each sale materialized. Like in other kinds of business, a great deal of the profits in affiliate marketing depends on the affiliate’s advertising, promoting and selling strategies. Everyday, as affiliate marketing industry expands, competition heightens as well so an affiliate marketer must be creative enough to employ unique and effective ways to convince potential buyers to purchase or avail of the products and services offered.
Compared to traditional advertising practices, affiliate programs are more effective, risk-free and cost-efficient. But why do many people still fail in affiliate marketing?
Labels:
Agency,
alliance,
Alzheimers,
appointment,
Preapproved,
profitability,
progress,
proposes,
Report,
Retirement,
Suppression,
survey,
Takes
Saturday, June 29, 2013
Make Money Online With Affiliate Programs
Make Money Online With Affiliate Programs
Broadly speaking, affiliate program seems including everything, no matter as hot as pay per click advertising or as old as pay per impression or pay per sale or lead marketing. So, it is true that all businesses, no matter big or small, are making money online with affiliate programs. The doubt is only how to select suitable affiliate programs to make money.
What is a partner? What is an affiliate? A partner is an associate who works with others toward a common goal. An affiliate is a subsidiary or subordinate organization that is affiliated with another organization. It seems the difference is there but the basic meaning is the same –
Subscribe to:
Posts (Atom)